ENAPOTAMAB VEDOTIN

UNII: 43HH4XYH2N
Preferred Substance Name: ENAPOTAMAB VEDOTIN

1912424-97-5
AXL-107-MMAE
ENAPOTAMAB VEDOTIN [INN]
ENAPOTAMAB VEDOTIN [WHO-DD]
HUMAXAXLADC
HUMAX-AXL-ADC
IMMUNOGLOBULIN G1, ANTI-(HUMAN GROWTH FACTOR RECEPTOR AXL)(HUMAN HUMAX-AXL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN HUMAX-AXL .KAPPA.-CHAIN, DIMER TETRAKIS(THIOETHER) WITH VEDOTIN
IMMUNOGLOBULIN G1, ANTI-(HUMAN GROWTH FACTOR RECEPTOR AXL)(HUMAN HUMAX-AXL GAMMA LIGHT CHAIN), DISULFIDE WITH HUMAN HUMAX-AXL KAPPA CHAIN, DIMER, MONOMETHYL AURISTATIN E CONJUGATE

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

ENAPOTAMAB VEDOTIN

Synonyms and Mappings

Resources

Note